(Q44407524)

2 December 2017

Histopathology of the lung following intratracheal challenge with live Pseudomonas aeruginosa in intestinally immunized rats (English)

1 reference

2 December 2017

0 references

Pseudomonas aeruginosa

1 reference

Wilson NR

1

1 reference

2 December 2017

Dunkley ML

2

1 reference

2 December 2017

Buret A

3

1 reference

2 December 2017

Young B

4

1 reference

2 December 2017

Cripps AW

5

1 reference

2 December 2017

1 October 1995

1 reference

Immunology & Cell Biology

2 December 2017

1 reference

2 December 2017

73

1 reference

2 December 2017

5

1 reference

2 December 2017

440-445

1 reference

Microbiology of airway disease in patients with cystic fibrosis

2 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

An important role for intestinally derived T cells in respiratory defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

Immunopathology of experimental bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Immunologic aspects of surface infections in the lung

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.68

7 January 2021

Identifiers

DOI

10.1038/ICB.1995.68

1 reference

2 December 2017

1 reference